7551 - 7600 of 8818 Results
Title
Year
-
OPENTitle: Mitochondrial complex IV defects induce metabolic and signaling perturbations that expose potential vulnerabilities in HCT116 cellsJournal Name: FEBS Open BioPublisher: WileyVol: 12Issue #: 5Start Page: 959End Page: 982Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/2211-5463.13398Best OA location URL: https://doi.org/10.1002/2211-5463.13398Citation Count: 7
-
OPENTitle: Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsyJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 34Issue #:Start Page: 103022End Page: 103022Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2022.103022Best OA location URL: https://doi.org/10.1016/j.nicl.2022.103022Citation Count: 27
-
OPENTitle: Long-Term Persistence and Monotherapy with Device-Aided Therapies: A Retrospective Analysis of an Israeli Cohort of Patients with Advanced Parkinson’s DiseaseJournal Name: Advances in TherapyPublisher: Springer Science and Business Media LLCVol: 39Issue #: 5Start Page: 2009End Page: 2024Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s12325-022-02072-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s12325-022-02072-x.pdfCitation Count: 5
-
OPENTitle: Proposed research criteria for prodromal behavioural variant frontotemporal dementiaJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 3Start Page: 1079End Page: 1097Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awab365Best OA location URL: https://academic.oup.com/brain/article-pdf/145/3/1079/43500015/awab365.pdfCitation Count: 77
-
OPENTitle: Alzheimer’s Disease Variant Portal: A Catalog of Genetic Findings for Alzheimer’s DiseaseJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 86Issue #: 1Start Page: 461End Page: 477Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jad-215055Best OA location URL: https://content.iospress.com:443/download/journal-of-alzheimers-disease/jad215055?id=journal-of-alzheimers-disease%2Fjad215055Citation Count: 13
-
OPENTitle: Long-term adherence of human brain cells in vitro is enhanced by charged amine-based plasma polymer coatingsJournal Name: Stem Cell ReportsPublisher: Elsevier BVVol: 17Issue #: 3Start Page: 489End Page: 506Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.stemcr.2022.01.013Best OA location URL: http://www.cell.com/article/S2213671122000571/pdfCitation Count: 15
-
OPENTitle: Lipid level alteration in human and cellular models of alpha synuclein mutationsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00313-yBest OA location URL: https://www.nature.com/articles/s41531-022-00313-y.pdfCitation Count: 14
-
OPENTitle: Does Prefrontal Glutamate Index Cognitive Changes in Parkinson’s Disease?Journal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page: 809905End Page: 809905Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2022.809905Best OA location URL: https://doi.org/10.3389/fnhum.2022.809905Citation Count: 7
- Combining Neuroimaging and Omics Datasets for Disease Classification Using Graph Neural Networks2022OPENTitle: Combining Neuroimaging and Omics Datasets for Disease Classification Using Graph Neural NetworksJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2022.866666Best OA location URL: https://doi.org/10.3389/fnins.2022.866666Citation Count: 27
-
OPENTitle: Electrocorticography is superior to subthalamic local field potentials for movement decoding in Parkinson’s diseaseJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.75126Best OA location URL: https://doi.org/10.7554/elife.75126Citation Count: 60
-
OPENTitle: Image Quantification for TSPO PET with a Novel Image-Derived Input Function MethodJournal Name: DiagnosticsPublisher: MDPI AGVol: 12Issue #: 5Start Page: 1161End Page: 1161Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/diagnostics12051161Best OA location URL: https://www.mdpi.com/2075-4418/12/5/1161/pdf?version=1652773802Citation Count: 11
-
OPENTitle: Distinct profiles of LRRK2 activation and Rab GTPase phosphorylation in clinical samples from different PD cohortsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00336-5Best OA location URL: https://www.nature.com/articles/s41531-022-00336-5.pdfCitation Count: 20
-
OPENTitle: Structural basis for feedforward control in the PINK1/Parkin pathwayJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 41Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.15252/embj.2021109460Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/embj.2021109460Citation Count: 21
-
OPENTitle: Aβ oligomer concentration in mouse and human brain and its drug-induced reduction ex vivoJournal Name: Cell Reports MedicinePublisher: Elsevier BVVol: 3Issue #: 5Start Page: 100630End Page: 100630Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.xcrm.2022.100630Best OA location URL: http://www.cell.com/article/S2666379122001550/pdfCitation Count: 26
-
OPENTitle: Explainable machine learning with pairwise interactions for the classification of Parkinson’s disease and SWEDD from clinical and imaging featuresJournal Name: Brain Imaging and BehaviorPublisher: Springer Science and Business Media LLCVol: 16Issue #: 5Start Page: 2188End Page: 2198Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11682-022-00688-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11682-022-00688-9.pdfCitation Count: 21
-
OPENTitle: Analysis of hemisphere-dependent effects of unilateral intrastriatal injection of α-synuclein pre-formed fibrils on mitochondrial protein levels, dynamics, and functionJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 78End Page: 78Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-022-01374-zBest OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-022-01374-zCitation Count: 10
-
OPENTitle: Transcriptional landscape of human microglia implicates age, sex, and APOE‐related immunometabolic pathway perturbationsJournal Name: Aging CellPublisher: WileyVol: 21Issue #: 5Start Page: e13606End Page: e13606Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/acel.13606Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/acel.13606Citation Count: 52
-
OPENTitle: Path analysis of biomarkers for cognitive decline in early Parkinson’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 17Issue #: 5Start Page: e0268379End Page: e0268379Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0268379Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0268379&type=printableCitation Count: 2
-
OPENTitle: Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in proteinJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00322-xBest OA location URL: https://www.nature.com/articles/s41531-022-00322-x.pdfCitation Count: 9
-
OPENTitle: Brain atrophy pattern in de novo Parkinson’s disease with probable RBD associated with cognitive impairmentJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00326-7Best OA location URL: https://www.nature.com/articles/s41531-022-00326-7.pdfCitation Count: 20
-
OPENTitle: Virtual exam for Parkinson’s disease enables frequent and reliable remote measurements of motor functionJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-022-00607-8Best OA location URL: https://www.nature.com/articles/s41746-022-00607-8.pdfCitation Count: 63
-
OPENTitle: Uncovering clinical and radiological asymmetry in progressive supranuclear palsy—Richardson’s syndromeJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 43Issue #: 6Start Page: 3677End Page: 3682Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s10072-022-05919-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s10072-022-05919-x.pdfCitation Count: 7
-
OPENTitle: Sleep, Pain, and Neurodegeneration: A Mendelian Randomization StudyJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.765321Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.765321/pdfCitation Count: 18
- Altered Cholinergic Innervation in De Novo Parkinson's Disease with and Without Cognitive Impairment2022OPENTitle: Altered Cholinergic Innervation in De Novo Parkinson's Disease with and Without Cognitive ImpairmentJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 4Start Page: 713End Page: 723Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28913Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28913Citation Count: 61
- Differential Phospho‐Signatures in Blood Cells Identify LRRK2 G2019S Carriers in Parkinson's Disease2022OPENTitle: Differential Phospho‐Signatures in Blood Cells Identify LRRK2 G2019S Carriers in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 1004End Page: 1015Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28927Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28927Citation Count: 14
-
OPENTitle: Targeting retinoic acid receptor alpha-corepressor interaction activates chaperone-mediated autophagy and protects against retinal degenerationJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-022-31869-1Best OA location URL: https://www.nature.com/articles/s41467-022-31869-1.pdfCitation Count: 39
-
OPENTitle: A versatile fluorescence-quenched substrate for quantitative measurement of glucocerebrosidase activity within live cellsJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 119Issue #: 29Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2200553119Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9304032Citation Count: 25
-
OPENTitle: Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as BiomarkersJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 4Start Page: 669End Page: 683Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28941Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28941Citation Count: 78
-
OPENTitle: Neuromelanin‐MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template‐Based Standardized AnalysisJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 1028End Page: 1039Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28934Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28934Citation Count: 25
-
OPENTitle: Adenosine A2A Receptor Occupancy by Caffeine After Coffee Intake in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 4Start Page: 853End Page: 857Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28897Best OA location URL: https://doi.org/10.1002/mds.28897Citation Count: 19
-
OPENTitle: A Randomized, Double‐Blind, Controlled Phase II Study of Foliglurax in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 1088End Page: 1093Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28970Best OA location URL: https://doi.org/10.1002/mds.28970Citation Count: 31
-
OPENTitle: Deep Learning‐Based Neuromelanin MRI Changes of Isolated REM Sleep Behavior DisorderJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 1064End Page: 1069Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28933Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28933Citation Count: 27
-
OPENTitle: Frequency of spinocerebellar ataxia mutations in patients with multiple system atrophyJournal Name: Clinical Autonomic ResearchPublisher: Springer Science and Business Media LLCVol: 31Issue #: 1Start Page: 117End Page: 125Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10286-020-00759-1Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9302534Citation Count: 12
-
OPENTitle: Self‐Report versus Clinician Examination in Early Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 585End Page: 597Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28884Best OA location URL: https://doi.org/10.1002/mds.28884Citation Count: 23
- Subcutaneous Levodopa Infusion for Parkinson's Disease: 1‐Year Data from the Open‐Label BeyoND Study2021OPENTitle: Subcutaneous Levodopa Infusion for Parkinson's Disease: 1‐Year Data from the Open‐Label BeyoND StudyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2687End Page: 2692Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28758Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28758Citation Count: 34
-
OPENTitle: A multiplex pedigree with pathologically confirmed multiple system atrophy and Parkinson’s disease with dementiaJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 4Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcac175Best OA location URL: https://academic.oup.com/braincomms/article-pdf/4/4/fcac175/45028340/fcac175.pdfCitation Count: 6
-
OPENTitle: Evaluation of Disability Progression in Multiple Sclerosis via Magnetic-Resonance-Based Deep Learning TechniquesJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 18Start Page: 10651End Page: 10651Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms231810651Best OA location URL: https://www.mdpi.com/1422-0067/23/18/10651/pdf?version=1663318573Citation Count: 13
- Deep Learning for Daily Monitoring of Parkinson’s Disease Outside the Clinic Using Wearable Sensors2022OPENTitle: Deep Learning for Daily Monitoring of Parkinson’s Disease Outside the Clinic Using Wearable SensorsJournal Name: SensorsPublisher: MDPI AGVol: 22Issue #: 18Start Page: 6831End Page: 6831Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/s22186831Best OA location URL: https://www.mdpi.com/1424-8220/22/18/6831/pdf?version=1662721899Citation Count: 25
-
OPENTitle: Druggable transcriptomic pathways revealed in Parkinson’s patient-derived midbrain neuronsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 134End Page: 134Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00400-0Best OA location URL: https://www.nature.com/articles/s41531-022-00400-0.pdfCitation Count: 18
-
OPENTitle: Parkinson’s disease-associated, sex-specific changes in DNA methylation at PARK7 (DJ-1), SLC17A6 (VGLUT2), PTPRN2 (IA-2β), and NR4A2 (NURR1) in cortical neuronsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 120End Page: 120Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00355-2Best OA location URL: https://www.nature.com/articles/s41531-022-00355-2.pdfCitation Count: 59
-
OPENTitle: Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathologyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 126End Page: 126Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00397-6Best OA location URL: https://www.nature.com/articles/s41531-022-00397-6.pdfCitation Count: 78
-
OPENTitle: Subcellular and regional localization of mRNA translation in midbrain dopamine neuronsJournal Name: Cell ReportsPublisher: Elsevier BVVol: 38Issue #: 2Start Page: 110208End Page: 110208Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.celrep.2021.110208Best OA location URL: http://www.cell.com/article/S2211124721017125/pdfCitation Count: 46
-
OPENTitle: Mapping dopaminergic projections in the human brain with resting-state fMRIJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.71846Best OA location URL: https://doi.org/10.7554/elife.71846Citation Count: 36
-
OPENTitle: Antemortem detection of Parkinson’s disease pathology in peripheral biopsies using artificial intelligenceJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 21End Page: 21Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-022-01318-7Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-022-01318-7Citation Count: 16
-
OPENTitle: Sex-Related Longitudinal Change of Motor, Non-Motor, and Biological Features in Early Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 1Start Page: 421End Page: 436Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212892Best OA location URL: https://escholarship.org/uc/item/25m1h6q7Citation Count: 29
-
OPENTitle: One-Carbon Metabolism in Alzheimer’s Disease and Parkinson’s Disease Brain TissueJournal Name: NutrientsPublisher: MDPI AGVol: 14Issue #: 3Start Page: 599End Page: 599Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/nu14030599Best OA location URL: https://www.mdpi.com/2072-6643/14/3/599/pdf?version=1643524082Citation Count: 25
-
OPENTitle: Comprehensive short and long read sequencing analysis for the Gaucher and Parkinson’s disease-associated GBA geneJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s42003-022-03610-7Best OA location URL: https://www.nature.com/articles/s42003-022-03610-7.pdfCitation Count: 37
-
OPENTitle: Association Between Dopaminergic Medications and the Evolution of REM Sleep Behavior Disorder in Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.880583Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.880583/pdfCitation Count: 4
- Associations of Sleep Disorders With Depressive Symptoms in Early and Prodromal Parkinson’s Disease2022OPENTitle: Associations of Sleep Disorders With Depressive Symptoms in Early and Prodromal Parkinson’s DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.898149Best OA location URL: https://doi.org/10.3389/fnagi.2022.898149Citation Count: 4
- Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept Trial2021OPENTitle: Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2408End Page: 2412Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28702Best OA location URL: https://doi.org/10.1002/mds.28702Citation Count: 16